Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.20.2
Significant Accounting Policies (Tables)
9 Months Ended
Oct. 31, 2020
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of cash, cash equivalents and restricted cash that constitutes the total amounts shown in the consolidated statements of cash flows as of October 31, 2020 and 2019:

 

 

 

As of October 31,

 

 

 

2020

 

 

2019

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

4,904

 

 

$

5,598

 

Restricted cash

 

 

220

 

 

 

289

 

Total cash, cash equivalents and restricted cash

 

$

5,124

 

 

$

5,887

 

Schedule of Anti-dilutive Securities Excluded from Computation of Loss Per Share

The number of common shares used in the computation of diluted net (loss) income per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive:

 

 

 

For the Three Months

Ended October 31,

 

 

For the Nine Months

Ended October 31,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Amounts in thousands)

 

 

(Amounts in thousands)

 

Stock options

 

 

2,643

 

 

 

1,011

 

 

 

1,072

 

 

 

2,820

 

Restricted stock units

 

 

341

 

 

 

 

 

 

58

 

 

 

130

 

Deferred stock units

 

 

313

 

 

 

 

 

 

82

 

 

 

201

 

Performance stock units

 

 

 

 

 

 

 

 

 

 

 

112

 

 

 

 

3,297

 

 

 

1,011

 

 

 

1,212

 

 

 

3,263